Ari-Pekka Laitsaari
Plus aucun poste en cours
Provenance du réseau au premier degré de Ari-Pekka Laitsaari
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Hermo Pharma Oy
 Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd.
11
| Extinct | Pharmaceuticals: Major | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ari-Pekka Laitsaari via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| VARIAN MEDICAL SYSTEMS, INC. | Medical Specialties | Corporate Officer/Principal | |
| REVVITY, INC. | Medical Specialties | Corporate Officer/Principal | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ACCENTURE PLC | Information Technology Services | Corporate Officer/Principal | |
Immunophotonics, Inc.
 Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Corporate Officer/Principal | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chief Executive Officer | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Hever Group
 Hever Group Personnel ServicesCommercial Services Part of Amrop International, Hever Group is a British company that provides headhunting services. The company is based in London, UK. Hever Group was acquired by Amrop International on June 15, 2000. | Personnel Services | Chairman | |
Orion Pharma Oy
 Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | Pharmaceuticals: Major | President Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Mobidiag Oy
 Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| University of Turku | College/University | Doctorate Degree | |
| FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Director/Board Member | |
| BIORETEC OY | Medical Specialties | Director/Board Member | |
Medix Biochemica Oy Ab
 Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Medix Biochemica Oy Ab develops, produces, and markets monoclonal antibodies, antibody services, and recombinant antigens for in vitro diagnostics industry. It also provides rapid tests for human healthcare. The company was founded in 1985 and is headquartered in Espoo, Finland. | Medical Specialties | Director/Board Member | |
| Aalto University | College/University | Graduate Degree | |
| University of Tartu | College/University | Doctorate Degree | |
| University of Oulu | College/University | Undergraduate Degree | |
| University of Kuopio | College/University | Corporate Officer/Principal | |
| University of Helsinki | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| European Molecular Biology Organization | Director/Board Member | ||
Domainex Ltd.
 Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Dassiet Oy
 Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Medical Specialties | Chief Executive Officer | |
Lundbeck Ltd.
 Lundbeck Ltd. Pharmaceuticals: MajorHealth Technology Lundbeck Ltd. engages in the research, development, production, marketing and sale of pharmaceuticals. It provides services that aid in the treatment of CNS disorders, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia. The company was founded in 1972 and is headquartered in St. Albans, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Suomen Bioteollisuus ry | Chairman Chairman | ||
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Kemianteollisuus ry | Director/Board Member | ||
MediSapiens Oy
 MediSapiens Oy Packaged SoftwareTechnology Services MediSapiens Oy provides solutions for bioinformatics analysis. It offers software and products for biological research. The firm creates customized bioinformatics software solutions to organizations; ranging from data management system, to full sample and data processing system, to an animal deoxyribonucleic acid testing service. Its products include Biond Explorer; Research Integrator; IST Online; Target Scout; and Fusion Scout. The company was founded by Sami Kalevi Kilpinen, Olli-Pekka Kallioniemi, and Tommi Pisto in 2009 and is headquartered in Helsinki, Finland. | Packaged Software | Director/Board Member Director/Board Member | |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Founder | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Chairman Director/Board Member Founder Chairman Chief Executive Officer Founder Compliance Officer | |
Innovestor Oy
 Innovestor Oy Investment ManagersFinance Innovestor Oy is a venture and growth equity firm headquartered in Helsinki, Finland. The firm was founded by Tommi Äijälä and Antti Parviainen in 2014. | Investment Managers | Private Equity Analyst | |
TILT Biotherapeutics Oy
 TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member | |
| BAUDAX BIO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Innovestor Ventures Oy
 Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor | |
| Neurotar Oy | Director/Board Member | ||
Meles Consulting Oy
 Meles Consulting Oy Miscellaneous Commercial ServicesCommercial Services Meles Consulting Oy provides management consulting services. The private company is based in Espoo, Finland. The CEO of the Finnish company is Pekka Ilmari Simula. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Master Golf Course Oy AB | Chairman | ||
| Sartar Therapeutics Oy | Director/Board Member | ||
HVR Cardio Oy
 HVR Cardio Oy Medical SpecialtiesHealth Technology HVR Cardio Oy is a Finnish cardiovascular device company that is developing breakthrough solutions for mitral valve repair based on its proprietary helix technology. The company is based in Espoo, Finland. The company's lead products, CathHELIX® and MAR®, are transcatheter and surgical mitral valve repair devices that are designed to be faster, easier to use, and less invasive without compromising clinical efficacy. The company was founded by Olli Urho Tapani Keränen, and Tom Fleming has been the CEO of the company since 2022. | Medical Specialties | Director/Board Member | |
BiopSense Oy
 BiopSense Oy BiotechnologyHealth Technology BiopSense Oy is a Finnish medical technology company that specializes in liquid biopsy services and technology development. The company is based in Jyvaskyla, Finland. BiopSense was founded by Marja Tiirola, Juha Kononen, and Veli-Mikko Puupponen, with Marja Tiirola serving as the CEO since incorporation. | Biotechnology | Director/Board Member | |
| AIFORIA TECHNOLOGIES OYJ | Packaged Software | Chairman | |
| Biotie Therapies International Oy | Director/Board Member |
Statistiques
Internationale
| Finlande | 34 |
| Etats-Unis | 10 |
| Royaume-Uni | 4 |
| Belgique | 3 |
| Irlande | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 9 |
| Technology Services | 5 |
| Commercial Services | 5 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 47 |
| Corporate Officer/Principal | 28 |
| Chief Executive Officer | 14 |
| Chairman | 14 |
| Chief Tech/Sci/R&D Officer | 9 |
Relations les plus connectées
- Bourse
- Insiders
- Ari-Pekka Laitsaari
- Connexions Sociétés
